Literature DB >> 9854031

N-lobe versus C-lobe complexation of bismuth by human transferrin.

H Sun1, H Li, A B Mason, R C Woodworth, P J Sadler.   

Abstract

Interactions of recombinant N-lobe of human serum transferrin (hTF/2N) with Bi3+, a metal ion widely used in medicine, have been investigated by both UV and NMR spectroscopy. The bicarbonate-independent stability constant for Bi3+ binding (K*) to hTF/2N was determined to be log K* 18.9+/-0.2 in 5 mM bicarbonate/10 mM Hepes buffer at 310 K, pH7.4. The presence of Fe3+ in the C-lobe of intact hTF perturbed Bi3+ binding to the N-lobe, whereas binding of Bi3+ to the C-lobe was unaffected by the presence of Fe3+ in the N-lobe. Reactions of Bi3+ (as bismuth nitrilotriacetate or ranitidine bismuth citrate) with hTF/2N in solutions containing 10 mM bicarbonate induced specific changes to high-field 1H-NMR peaks. The 1H co-ordination shifts induced by Bi3+ were similar to those induced by Fe3+ and Ga3+, suggesting that Bi3+ binding causes similar structural changes to those induced by hTF/2N. 13C-NMR data showed that carbonate binds to hTF/2N concomitantly with Bi3+.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9854031      PMCID: PMC1219942     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

Review 1.  Proteins of iron storage and transport.

Authors:  R R Crichton
Journal:  Adv Protein Chem       Date:  1990

2.  Molecular structure of serum transferrin at 3.3-A resolution.

Authors:  S Bailey; R W Evans; R C Garratt; B Gorinsky; S Hasnain; C Horsburgh; H Jhoti; P F Lindley; A Mydin; R Sarra
Journal:  Biochemistry       Date:  1988-07-26       Impact factor: 3.162

3.  Structure of human lactoferrin at 3.2-A resolution.

Authors:  B F Anderson; H M Baker; E J Dodson; G E Norris; S V Rumball; J M Waters; E N Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

4.  Distribution of iron between the binding sites of transferrin in serum: methods and results in normal human subjects.

Authors:  A Leibman; P Aisen
Journal:  Blood       Date:  1979-06       Impact factor: 22.113

5.  Trp128Tyr mutation in the N-lobe of recombinant human serum transferrin: 1H- and 15N-NMR and metal binding studies.

Authors:  E J Beatty; M C Cox; T A Frenkiel; Q Y He; A B Mason; P J Sadler; A Tucker; R C Woodworth
Journal:  Protein Eng       Date:  1997-05

6.  Metal site conformational states of vanadyl(IV) human serotransferrin complexes.

Authors:  N D Chasteen; L K White; R F Campbell
Journal:  Biochemistry       Date:  1977-02-08       Impact factor: 3.162

7.  [1H,13C] NMR determination of the order of lobe loading of human transferrin with iron: comparison with other metal ions.

Authors:  H Sun; M C Cox; H Li; A B Mason; R C Woodworth; P J Sadler
Journal:  FEBS Lett       Date:  1998-02-06       Impact factor: 4.124

8.  Rationalization of the strength of metal binding to human serum transferrin.

Authors:  H Li; P J Sadler; H Sun
Journal:  Eur J Biochem       Date:  1996-12-01

9.  Thermodynamic binding constants of the zinc-human serum transferrin complex.

Authors:  W R Harris
Journal:  Biochemistry       Date:  1983-08-02       Impact factor: 3.162

10.  Apolactoferrin structure demonstrates ligand-induced conformational change in transferrins.

Authors:  B F Anderson; H M Baker; G E Norris; S V Rumball; E N Baker
Journal:  Nature       Date:  1990-04-19       Impact factor: 49.962

View more
  3 in total

1.  Indirect detection of protein-metal binding: interaction of serum transferrin with In3+ and Bi3+.

Authors:  Mingxuan Zhang; Dmitry R Gumerov; Igor A Kaltashov; Anne B Mason
Journal:  J Am Soc Mass Spectrom       Date:  2004-11       Impact factor: 3.109

2.  Can uranium follow the iron-acquisition pathway? Interaction of uranyl-loaded transferrin with receptor 1.

Authors:  Miryana Hémadi; Ngûyet-Thanh Ha-Duong; Sophie Plantevin; Claude Vidaud; Jean-Michel El Hage Chahine
Journal:  J Biol Inorg Chem       Date:  2009-12-30       Impact factor: 3.358

Review 3.  Current and potential applications of bismuth-based drugs.

Authors:  Donal M Keogan; Darren M Griffith
Journal:  Molecules       Date:  2014-09-23       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.